|
As Samuel J. Klempner, M.D. approaches the completion of his three years as a Ben Feinstein Memorial Research Scholar, he’s reporting promising results from the research he was able to accomplish with the funding he received from Gastric Cancer Foundation and the American Gastroenterology Association (AGA)
Klempner, a medical oncologist at Massachusetts General Hospital, was awarded the $300,000 grant in 2020. His plan was to explore tumor and immune features of “peritoneal disease”—the migration of cancer cells into the lining of the abdomen. About 40% of gastric cancer patients experience this problem, which is associated with shorter survival and lesser benefit from immunotherapies. Klempner’s work has focused in on the composition of the abdominal fluid in gastric cancer patients with peritoneal spread, which is called the ascites (uh-SY-tees).
|